Shephard Mpofu
Directeur Technique/Scientifique/R&D chez ACELYRIN, INC.
Profil
Shephard Mpofu is currently working as the Chief Medical Officer at ACELYRIN, Inc. since 2024.
Previously, he worked at Novartis Gene Therapies, Inc. as the Chief Medical Officer & Senior Vice President.
Dr. Mpofu completed his undergraduate degree at the University of Zimbabwe.
Postes actifs de Shephard Mpofu
| Sociétés | Poste | Début |
|---|---|---|
| ACELYRIN, INC. | Directeur Technique/Scientifique/R&D | 09/05/2024 |
Anciens postes connus de Shephard Mpofu
| Sociétés | Poste | Fin |
|---|---|---|
| AVEXIS INC | Directeur Technique/Scientifique/R&D | - |
Formation de Shephard Mpofu
| University of Zimbabwe | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ACELYRIN, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Novartis Gene Therapies, Inc.
 Novartis Gene Therapies, Inc. BiotechnologyHealth Technology Novartis Gene Therapies, Inc. developed gene therapies for patients and families devastated by rare and life-threatening neurological genetic diseases. The firm’s robust AAV-based pipeline is used to provide advance treatments for Rett syndrome and Friedreich’s ataxia. The company was founded by John D. Harkey, Jr., David G. Genecov and John A. Carbona on March 8, 2010 and was headquartered in Bannockburn, IL. | Health Technology |
